Overall, our study may have the potential to uncover a relevant link between the guardian of our genome (i.e., BRCA1) and a master regulator of cell proliferation (i.e., TAZ), which might represent an evolutionary response of cancer cells to the detrimental effects of the loss of genome integrity pathways. This evidence concerns the gene BRCA1 and cancer.